Study details
Enrolling now
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
Rachel Miller
NCT IDNCT03089554ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
93
Study length
about 9.1 years
Ages
18+
Locations
1 site in KY
About this study
Researchers are testing a treatment based on genomic analysis results to see if it helps people with cancer live longer. The trial will last for 3306 days and involve approximately 93 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Therapeutic Intervention
PhasePhase 2
Primary goalProgression Free Survival
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Progression Free Survival
Body systems
Oncology